Karen Miga Fills In Missing Pieces of Our Genome

  • Thread starter Astronuc
  • Start date
In summary, Karen Miga's fascination with highly repetitive sections of DNA led her to lead a coalition of researchers to complete the sequencing of the human genome after almost two decades. Despite the Human Genome Project finishing a rough draft in 2001, Miga knew that the sequencing was far from complete, as only 90% of the genome was sequenced, leaving out the tightly packed heterochromatin sections. In 2018, Miga and Adam Phillippy launched the Telomere-to-Telomere consortium to finally sequence every last nucleotide of human DNA. Miga's work has helped fill in the missing pieces of our genome and is a great achievement in the field of genetics.
  • #1
Astronuc
Staff Emeritus
Science Advisor
2023 Award
21,913
6,338
Cool story and interesting biology.
https://www.quantamagazine.org/karen-miga-fills-in-the-missing-pieces-of-our-genome-20210908/
Driven by her fascination with highly repetitive, hard-to-read parts of our DNA, Karen Miga led a coalition of researchers to finish sequencing the human genome after almost two decades.

By 2001 the Human Genome Project (HGP) had prepared a rough draft, and in April 2003, the draft sequence was declared finished. But Karen Miga, a geneticist now at the University of California, Santa Cruz and the associate director of the UCSC Genomics Institute, knew that while the work might have wrapped up, the sequencing was far from complete.

The HGP was able to sequence the 90% of human DNA that geneticists call euchromatin, which is loosely folded and contains nearly all of the genes that are actively making proteins. But Miga specialized in heterochromatin, the tightly packed sections of DNA with highly repetitive sequences near the ends (telomeres) and centers (centromeres) of chromosomes. At the time, scientists couldn’t sequence heterochromatin, so despite the celebratory hubbub and champagne toasts, almost 10% of the genome went unsequenced.

Together with Adam Phillippy, a computational biologist at the National Human Genome Research Institute, Miga launched the Telomere-to-Telomere (T2T) consortium in 2018 to finally sequence every last nucleotide of human DNA.
 
  • Like
  • Informative
Likes pinball1970, Filip Larsen, jedishrfu and 7 others
Biology news on Phys.org
  • #2
I hadn't realized that all of it wasn't sequenced even after all these years. I remember the battle between Venter and Collins of the NIH and how Clinton "brokered" a truce between them. I also remember something about Venter using his own DNA in the sequencing effort.

In any event, this is a great achievement. Devil is in the details and now we know more of them thanks to Karen Miga's work.
 

1. What is the significance of Karen Miga's research on filling in missing pieces of our genome?

Karen Miga's research is significant because it helps us better understand the human genome and its functions. By filling in missing pieces of our genome, we can gain insights into genetic diseases and potentially develop new treatments.

2. How does Karen Miga's research contribute to the field of genetics?

Karen Miga's research contributes to the field of genetics by providing a more complete picture of the human genome. This can lead to advancements in genetic research, such as identifying new genes and understanding their role in diseases.

3. What methods does Karen Miga use to fill in missing pieces of our genome?

Karen Miga uses a combination of DNA sequencing technologies and computational algorithms to fill in missing pieces of our genome. This allows her to accurately piece together the genome, even in regions that were previously difficult to sequence.

4. What are the potential applications of Karen Miga's research?

The potential applications of Karen Miga's research are vast. It can aid in the diagnosis and treatment of genetic diseases, improve our understanding of human evolution, and potentially lead to the development of new therapies and treatments.

5. What are the challenges faced by Karen Miga in her research?

Some challenges faced by Karen Miga in her research include the complexity of the human genome and the limitations of current DNA sequencing technologies. Additionally, analyzing and interpreting large amounts of genomic data can also be a challenge.

Similar threads

Replies
2
Views
3K
Replies
2
Views
3K
Back
Top